ANI Pharmaceuticals, Inc. (ANIP) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 1.58B |
| Enterprise Value | 1.62B |
| P/E Ratio | 13.8 |
| PEG Ratio | 0.07 |
| Price/Sales Ratio | 1.58 |
| Price/Book Ratio | 2.38 |
| Enterprise/Revenue | 1.46 |
| Enterprise/EBITDA | 5.6 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | 0.11 |
| Operating Margin | 0.17 |
| Return On Assets | 0.07 |
| Return On Equity | 0.2 |
| Revenue | 883.37M |
| Revenue/Share | 49.09 |
| Gross Profit | 450.64M |
| EBITDA | 207.27M |
| Net Income | 78.34M |
| Diluted EPS | 3.32 |
| Total Cash | 436.35M |
| Total Cash/Share | 20.57 |
| Total Debt | 297.68M |
| Total Debt/Equity | 0.47 |
| Current Ratio | 2.75 |
| Book Value Per Share | 30.04 |
| 52-Week Change | -18.1 |
| 52-Week High | 87.89 |
| 52-Week Low | 67.14 |
| Moving Average 50 Days | 72.36 |
| Moving Average 200 Days | 77.1 |
| Average Volume | 412,357 |
| Shares Outstanding | 22.96M |
| % Held by Institutions | 109.74 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:6 |
| Last Split Date | July 18, 2013 |